Enveric Biosciences filed additional proxy materials to correct typographical errors in the reverse stock split range from 1-for-50 to 1-for-5 to 1-for-15 for its 2026 Annual Meeting on May 28, 2026.
Key takeaways
Filed definitive proxy statement on April 14, 2026, for Annual Meeting on May 28, 2026, at 10:00 a.m. ET.
Corrected reverse stock split range to 1-for-5 to 1-for-15 from erroneous 1-for-50 in proxy statement, proxy card, and notice.
Additional proxy materials filed April 30, 2026, with no changes to meeting date, time, location, or other proposals.
Proposals include election of six directors, say-on-pay, reverse stock split, authorized share increase to 5B, auditor ratification, and adjournment.